Epidemiology

Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis

Shintaro Akiyama, Shadi Hamdeh, Dejan Micic, Atsushi Sakuraba

10.1136/annrheumdis-2020-218946

October 13, 2020

High frequency of variants in genes associated with primary immunodeficiencies in patients with rheumatic diseases with secondary hypogammaglobulinaemia

Georgios Sogkas, Natalia Dubrowinskaja, Ignatius Ryan Adriawan, Manfred Anim, Torsten Witte, Reinhold E Schmidt, Faranaz Atschekzei

10.1136/annrheumdis-2020-218280

October 12, 2020

Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort

Adrian Ciurea, Eleftherios Papagiannoulis, Kristina Bürki, Isabell von Loga, Raphael Micheroli, Burkhard Möller, Andrea Rubbert-Roth, Michael Andor, René Bräm, Angela Müller, Diana Dan, Diego Kyburz, Oliver Distler, Almut Scherer, Axel Finckh

10.1136/annrheumdis-2020-218705

September 22, 2020

Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study

Jose L Pablos, María Galindo, Loreto Carmona, Ana Lledó, Miriam Retuerto, Ricardo Blanco, Miguel A Gonzalez-Gay, David Martinez-Lopez, Isabel Castrejón, José M Alvaro-Gracia, David Fernández Fernández, Antonio Mera-Varela, Sara Manrique-Arija, Natalia Mena Vázquez, Antonio Fernandez-Nebro, RIER investigators group, Rodrigo Aguirre, Álvaro Seijas-López, Francisco J Blanco, Patricia Carreira, María Martín-López, Antonio Gonzalez, Amaya Puig-Kröger, Luis Salas

10.1136/annrheumdis-2020-218296

August 12, 2020

Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases

Dalifer D Freites Nuñez, Leticia Leon, Arkaitz Mucientes, Luis Rodriguez-Rodriguez, Judit Font Urgelles, Alfredo Madrid García, Jose I Colomer, Juan A Jover, Benjamín Fernandez-Gutierrez, Lydia Abasolo

10.1136/annrheumdis-2020-217984

August 7, 2020

Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome

Mirko Scarsi, Silvia Piantoni, Enrico Colombo, Paolo Airó, Donata Richini, Marco Miclini, Valeria Bertasi, Marta Bianchi, Damiano Bottone, Patrizia Civelli, Maria-Sofia Cotelli, Ezio Damiolini, Gloria Galbassini, Diego Gatta, Maria-Laura Ghirardelli, Roberto Magri, Paola Malamani, Monia Mendeni, Stefano Molinari, Andrea Morotti, Luisa Salada, Marinella Turla, Angiola Vender, Angela Tincani, Antonio Brucato, Franco Franceschini, Roberto Furloni, Laura Andreoli

10.1136/annrheumdis-2020-217712

July 30, 2020

Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence–radiological differences

Piero Ruscitti, Federico Bruno, Onorina Berardicurti, Chiara Acanfora, Viktoriya Pavlych, Pierpaolo Palumbo, Alessandro Conforti, Francesco Carubbi, Ilenia Di Cola, Paola Di Benedetto, Paola Cipriani, Davide Grassi, Carlo Masciocchi, Annamaria Iagnocco, Antonio Barile, Roberto Giacomelli

10.1136/annrheumdis-2020-218048

July 21, 2020

Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study

Sofia Ramiro, Rémy L M Mostard, César Magro-Checa, Christel M P van Dongen, Tom Dormans, Jacqueline Buijs, Michiel Gronenschild, Martijn D de Kruif, Eric H J van Haren, Tom van Kraaij, Mathie P G Leers, Ralph Peeters, Dennis R Wong, Robert B M Landewé

10.1136/annrheumdis-2020-218479

July 20, 2020

Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study

Emanuel Della-Torre, Corrado Campochiaro, Giulio Cavalli, Giacomo De Luca, Angela Napolitano, Salvatore La Marca, Nicola Boffini, Valentina Da Prat, Gaetano Di Terlizzi, Marco Lanzillotta, Patrizia Rovere Querini, Annalisa Ruggeri, Giovanni Landoni, Moreno Tresoldi, Fabio Ciceri, ALberto Zangrillo, Francesco De Cobelli, Lorenzo Dagna, SARI-RAF Study Group members, Piera Angelillo, Andrea Assanelli, Elena Baldissera, Nicola Boffini, Enrica Paola Bozzolo, Stefania Calvisi, Corrado Campochiaro, Valentina Da Prat, Diana Canetti, Adriana Cariddi, Antonella Castagna, Giulio Cavalli, Maria Pia Cicalese, Fabio Ciceri, Lorenzo Dagna, Francesco De Cobelli, Giacomo De Luca, Emanuel Della-Torre, Giuseppe Di Lucca, Gaetano di Terlizzi, Nicola Farina, Maria Fazio, Salvatore La Marca, Giovanni Landoni, Marco Lanzillotta, Gaia Mancuso, Giacomo Monti, Luca Moroni, Angela Napolitano, Chiara Oltolini, Diego Palumbo, Marco Ripa, Patrizia Rovere-Querini, Annalisa Ruggeri, Silvia Sartorelli, Paolo Scarpellini, Marzia Spessot, Alessandro Tomelleri, Moreno Tresoldi, Alberto Zangrillo

10.1136/annrheumdis-2020-218122

July 3, 2020

Population characteristics as important contextual factors in rheumatological trials: an exploratory meta-epidemiological study from an OMERACT Working Group

Sabrina Mai Nielsen, Helene Storgaard, Torkell Ellingsen, Beverley J Shea, George A Wells, Vivian Andrea Welch, Daniel E Furst, Maarten de Wit, Marieke Voshaar, Carsten Bogh Juhl, Maarten Boers, Reuben Escorpizo, Thasia G Woodworth, Annelies Boonen, Henning Bliddal, Lyn M March, Peter Tugwell, Robin Christensen

10.1136/annrheumdis-2020-217237

June 30, 2020